** Medical device maker Enovis Corp ENOV.N down 4% at $35.76
** ENOV reiterates Q1 revenue forecast to be in the range of $555 million to $563 million vs analysts' estimate of $559.6 million, according to data compiled by LSEG
** Brokerage Evercore ISI analyst Vijay Kumar says shares are down partly because co reiterated Q1 forecast but did not mention forecast for the year
** Separately, ENOV appoints Damien McDonald as chief executive officer effective May 12, 2025
** CEO Matt Trerotola previously said in February his intention to retire
** Co says Trerotola will not stand for re-election
** Stock has fallen 18.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.